Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Wajed A. Alshammari"'
Autor:
Mohammed A. Omair, Tariq Alhawassi, Munira Alwaihibi, Ghada Aldrees, Mahmoud Mosli, Wesam M. Asser, Maryam A. Alharaibi, Atheer T. Alotaibi, Doaa A. Bintaleb, Najah K. Alharbi, Ahmed Z. Alotaibi, Wajed A. Alshammari, Nouf Alanazi, Ali M. Asiri, Rana Almadany, Hanan Al Rayes, Turki Al-Thunian, Moureq Alotaibi, Abdulrazaq Al Jazaeri
Publikováno v:
Saudi Pharmaceutical Journal, Vol 28, Iss 12, Pp 1827-1829 (2020)
The loss of patentability of many originator biologics has led to the rapid introduction of biosimilar agents. The anticipated economic benefit of introducing such agent has been accompanied by vagueness surrounding their biotechnology, approval requ
Externí odkaz:
https://doaj.org/article/18b68d61ece245bfac6ad4bab51d7038
Autor:
Mahmoud Mosli, Doaa A. Bintaleb, Turki Al-Thunian, Moureq R. Alotaibi, Wajed A. Alshammari, Hanan Al Rayes, Najah K. Alharbi, Ghada A Aldrees, Ali Mohammed Asiri, Rana Almadany, Mohammed A. Omair, Atheer T. Alotaibi, Ahmed Z. Alotaibi, Maryam A. Alharaibi, Munira Alwaihibi, Wesam M. Asser, Abdulrazaq Al Jazaeri, Nouf A. Alanazi, Tariq M. Alhawassi
Publikováno v:
Saudi Pharmaceutical Journal, Vol 28, Iss 12, Pp 1827-1829 (2020)
Saudi Pharmaceutical Journal : SPJ
Saudi Pharmaceutical Journal : SPJ
The loss of patentability of many originator biologics has led to the rapid introduction of biosimilar agents. The anticipated economic benefit of introducing such agent has been accompanied by vagueness surrounding their biotechnology, approval requ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52bfe5fabf8a9ccb347d1630f0fc1bd9
http://www.sciencedirect.com/science/article/pii/S1319016420302693
http://www.sciencedirect.com/science/article/pii/S1319016420302693